Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 32 studies | 52% ± 25% | |
| endothelial cell of lymphatic vessel | 20 studies | 37% ± 20% | |
| oligodendrocyte | 16 studies | 45% ± 16% | |
| oligodendrocyte precursor cell | 15 studies | 52% ± 22% | |
| endothelial cell | 11 studies | 28% ± 15% | |
| ciliated cell | 9 studies | 28% ± 8% | |
| pericyte | 8 studies | 25% ± 11% | |
| connective tissue cell | 7 studies | 44% ± 31% | |
| basal cell | 5 studies | 24% ± 7% | |
| astrocyte | 4 studies | 33% ± 13% | |
| adventitial cell | 4 studies | 58% ± 8% | |
| melanocyte | 4 studies | 44% ± 21% | |
| epithelial cell | 3 studies | 30% ± 16% | |
| macrophage | 3 studies | 41% ± 26% | |
| endothelial cell of vascular tree | 3 studies | 27% ± 9% | |
| capillary endothelial cell | 3 studies | 28% ± 13% | |
| abnormal cell | 3 studies | 40% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 92541.90 | 457 / 459 | 76% | 816.31 | 852 / 1118 |
| prostate | 81% | 20424.50 | 198 / 245 | 93% | 271.57 | 465 / 502 |
| skin | 81% | 33768.43 | 1474 / 1809 | 91% | 3034.31 | 430 / 472 |
| brain | 67% | 14233.46 | 1768 / 2642 | 95% | 464.99 | 669 / 705 |
| thymus | 96% | 43405.22 | 627 / 653 | 23% | 37.30 | 142 / 605 |
| bladder | 90% | 20458.19 | 19 / 21 | 24% | 59.73 | 121 / 504 |
| pancreas | 18% | 2591.15 | 58 / 328 | 88% | 377.32 | 156 / 178 |
| adipose | 100% | 81018.65 | 1199 / 1204 | 0% | 0 | 0 / 0 |
| uterus | 86% | 22683.78 | 146 / 170 | 12% | 21.64 | 56 / 459 |
| muscle | 91% | 33415.37 | 734 / 803 | 0% | 0 | 0 / 0 |
| stomach | 58% | 14754.44 | 209 / 359 | 33% | 111.22 | 94 / 286 |
| esophagus | 69% | 19951.19 | 999 / 1445 | 20% | 37.35 | 36 / 183 |
| blood vessel | 72% | 31174.35 | 966 / 1335 | 0% | 0 | 0 / 0 |
| lung | 33% | 6422.65 | 193 / 578 | 32% | 74.77 | 371 / 1155 |
| eye | 0% | 0 | 0 / 0 | 57% | 73.41 | 46 / 80 |
| heart | 52% | 13586.84 | 444 / 861 | 0% | 0 | 0 / 0 |
| intestine | 21% | 3464.21 | 206 / 966 | 22% | 52.65 | 115 / 527 |
| lymph node | 0% | 0 | 0 / 0 | 24% | 226.44 | 7 / 29 |
| ovary | 17% | 2895.72 | 30 / 180 | 7% | 7.15 | 28 / 430 |
| adrenal gland | 9% | 2138.77 | 22 / 258 | 3% | 9.65 | 7 / 230 |
| kidney | 4% | 456.01 | 4 / 89 | 4% | 3.69 | 34 / 901 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 6.44 | 3 / 45 |
| liver | 0% | 0 | 0 / 226 | 2% | 2.15 | 7 / 406 |
| spleen | 1% | 79.15 | 2 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 28.17 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0010642 | Biological process | negative regulation of platelet-derived growth factor receptor signaling pathway |
| GO_0001525 | Biological process | angiogenesis |
| GO_0048678 | Biological process | response to axon injury |
| GO_0042308 | Biological process | negative regulation of protein import into nucleus |
| GO_0051895 | Biological process | negative regulation of focal adhesion assembly |
| GO_0071638 | Biological process | negative regulation of monocyte chemotactic protein-1 production |
| GO_1900016 | Biological process | negative regulation of cytokine production involved in inflammatory response |
| GO_2000098 | Biological process | negative regulation of smooth muscle cell-matrix adhesion |
| GO_0014012 | Biological process | peripheral nervous system axon regeneration |
| GO_0042246 | Biological process | tissue regeneration |
| GO_2000405 | Biological process | negative regulation of T cell migration |
| GO_0048662 | Biological process | negative regulation of smooth muscle cell proliferation |
| GO_0000302 | Biological process | response to reactive oxygen species |
| GO_0007420 | Biological process | brain development |
| GO_0006629 | Biological process | lipid metabolic process |
| GO_0006006 | Biological process | glucose metabolic process |
| GO_0006869 | Biological process | lipid transport |
| GO_0060588 | Biological process | negative regulation of lipoprotein lipid oxidation |
| GO_0005615 | Cellular component | extracellular space |
| GO_0022626 | Cellular component | cytosolic ribosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0043025 | Cellular component | neuronal cell body |
| GO_0030425 | Cellular component | dendrite |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0015485 | Molecular function | cholesterol binding |
| GO_0005319 | Molecular function | lipid transporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | APOD |
| Protein name | Apolipoprotein D Apolipoprotein D (Apo-D) (ApoD) |
| Synonyms | |
| Description | FUNCTION: APOD occurs in the macromolecular complex with lecithin-cholesterol acyltransferase. It is probably involved in the transport and binding of bilin. Appears to be able to transport a variety of ligands in a number of different contexts. |
| Accessions | F8WBT9 ENST00000453131.1 C9JF17 ENST00000421243.5 ENST00000458447.5 ENST00000343267.8 P05090 C9JX71 |